Marker Therapeutics, Inc.MRKRNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 1↑166.0% | 4↑183.0% | 3↓5.8% | 7↑99.1% |
| Gross Profit | -18 | -2↑89.6% | -8↓340.1% | -7↑16.0% | -7↑3.2% |
| Operating Income | -29 | -39↓36.7% | -20↑49.9% | -15↑26.3% | -11↑23.7% |
| Net Income | -29 | -42↓45.9% | -30↑28.5% | -8↑72.5% | -11↓30.3% |
| EBITDA | -28 | -39↓40.1% | -17↑56.1% | -12↑30.6% | -11↑5.7% |
| EPS Diluted | -6.10 | -5.47↑10.3% | -3.58↑34.6% | -1.93↑46.1% | -1.19↑38.3% |